Intermittent pneumatic foot compression can activate blood fibrinolysis without changes in blood coagulability and platelet activation

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 5, 2005, Pages 660-664

  Kohro, S ^a   Yamakage, Michiaki ^a   Sato, K ^a   Sato, J I ^a   Namiki, A ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood coagulability; Blood fibrinolysis; Intermittent pneumatic foot compression; Platelet activation; Tissue type plasminogen activator

Indexed keywords

ACTIVATED PROTEIN C; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; LEG COMPRESSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; VISCOMETER;

ACTIVATED PROTEIN C RESISTANCE; ADULT; BLOOD COAGULATION; BLOOD VISCOSITY; CLOT RETRACTION; ENDOTHELIAL CELLS; FEMALE; FIBRINOLYSIS; FOOT; HUMANS; INTRAOPERATIVE PERIOD; MALE; PLATELET ACTIVATION; PRESSURE; REGIONAL BLOOD FLOW; THROMBOEMBOLISM; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 17844365569     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2005.00661.x     Document Type: Article

References (15)

1. Geerts WH, Pineo GF, Heit JA, Berggist D, Lassen MR, Colwell CW et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400S.
2. Silbersack Y, Taute BM, Hein W, Podhaisky H. Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br 2004; 86: 809-12.
3. Proctor MC, Greenfield LJ. Thromboprophylaxis in an academic medical center. Cardiovasc Surg 2001; 9: 426-30.
4. Whitelaw GP, Oladipo OJ, Shah BP, De Muth KA, Coffman J, Segal D. Evaluation of intermittent pneumatic compression devices. Orthopedics 2001; 24: 257-61.
5. Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997; 226: 306-13.
6. Kohro S, Yamakage M, Takahashi T, Ota K, Kondo M, Namiki A. Effects of intermittent pneumatic foot compression on blood coagulability and fibrinolysis assessed by a whole blood viscometer Sonoclot. J Anesth 2003; 17: 208-10.
7. Chouhan VD, Comerota AJ, Sun L, Harada R, Goughan JP, Rao AK. Inhibition of tissue factor pathway during intermittent pneumatic compression: a possible mechanism for antithrombotic effect. Arterioscler Thromb Vasc Biol 1999; 19: 2812-7.
8. Kohro S, Yamakage M, Takahashi T, Kondo M, Ota K, Namiki A. Intermittent pneumatic compression prevents venous stasis in the lower extremities in the lithotomy position. Can J Anesth 2002; 49: 144-7.
9. Malyszko J, Malyszko JS, Mysliwiec M. Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephritic syndrome. Blood Coagul Fibrin 2002; 13: 615-21.
10. Jurd KM, Stephens CJ, Black MM, Hunt BJ. Endothelial cell activation in cutaneous vasculitis. Clin Exp Dermatol 1996; 21: 28-32.
11. Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T et al. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thromb Res 2001; 101: 65-72.
12. Hett DA, Walker D, Pilkington SN, Smith DC. Sonoclot analysis. Br J Anaesth 1995; 75: 771-6.
13. Dai G, Tsukurov O, Orkin RW, Abbott WM, Kamm RD, Gertler JP. An in vitro cell culture system to study the influence of external pneumatic compression on endothelial function. J Vasc Surg 2000; 32: 977-87.
14. Niiya T, Yamakage M, Kamada Y, Namiki A. Evaluation of blood fibrinolysis by the use of celite-activated thromboelastography (Sonoclot™). Jpn J Anesthesiol 1999; 23: 1123-6.
15. Rosenfeld BA, Faraday N, Campbell D, Sakima N, Bell W. The effects of bedrest on circadian changes in hemostasis. Thromb Haemost 1994; 72: 281-4.